Literature DB >> 4553652

Inhibition of peptic activity in man by carbenoxolyne sodium.

A Berstad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4553652

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  7 in total

1.  Carbenoxolone sodium: its role in ulcer healing.

Authors:  M J Langman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  The preparation and purification of individual human pepsins by using diethylaminoethyl-cellulose.

Authors:  N B Roberts; W H Taylor
Journal:  Biochem J       Date:  1978-03-01       Impact factor: 3.857

3.  Effect of carbenoxolone sodium on aspirin-induced injury of the rat gastric mucosa.

Authors:  N D Yeomans; D J St John
Journal:  Am J Dig Dis       Date:  1974-03

4.  Hereditary aspects of duodenal ulceration: pepsin 1 secretion in relation to ABO blood groups and ABH secretor status.

Authors:  L Waft; N B Roberts; W H Taylor
Journal:  J Med Genet       Date:  1979-12       Impact factor: 6.318

Review 5.  Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective?

Authors:  P H Guth
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

Review 6.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Effects of carbenoxolone Na on acute and chronic gastric ulcer models in experimental animals.

Authors:  S Okabe; Y Takata; K Takeuchi; T Naganuma; K Takagi
Journal:  Am J Dig Dis       Date:  1976-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.